The "edge strand" hypothesis: Prediction and test of a mutational "hot-spot" on the transthyretin molecule associated with FAP amyloidogenesis

Amyloid

Volumn 3, Issue 2, 1996, Pages 75-85

  Serpell, Louise C ^a   Goldsteins, Gundars ^b   Dacklin, Ingrid ^b   Lundgren, Erik ^b   Blake, Colin C F ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UMEÅ UNIVERSITY   (Sweden)

Author keywords

Amyloid; Fap; Hot spot; Transthyretin; Variants; Strand

Indexed keywords

EID: 1842589542     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129609014359     Document Type: Article

References (38)

1. Costa P, Figueira A and Bravo F (1978). Amyloid fibril protein related to prealbumin in familial amyloidotic polyneuropathy. Proc Natl Acad Sci USA 75, 4499-4503
2. Kanda Y, Goodman D, Canfield R and Morgan F (1974). The amino acid sequence of human plasma prealbumin. J Biol Chem 249, 6796-6805
3. Blake CCF, Geisow MJ, Oatley SJ, Rerat B and Rerat C (1978). Structure of prealbumin secondary, tertiary and quaternary interactions determined by Fourier refinement at 1.8A. J Mol Biol 121, 339-356
4. Edelhoch H, Pages RA and Robbins J (1973). Binding of thyroxine and thyroxine analogs to human serum prealbumin. Biochem 12, 2773-2779
5. De La Paz P, Burridge JM, Oatley SJ and Blake CCF (1992). Multiple modes of binding of thyroid hormones and other iodothyronines to human plasma transthyretin. In The Design of Drugs to Macromolecular Targets, pp 119-172. (John Wiley and Sons Ltd)
6. Raz A and Goodman DS (1969). The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex. J Biol Chem 244, 3230-3237
7. Monaco HL, Rizzi M and Coda A (1995). Structure of a complex of 2 plasma-proteins-transthyretin and retinol binding protein. Science 268, 1039-1041
8. Saraiva MJM (1995). Transthyretin mutations in health and disease. Human Mutation 5, 191-196
9. Zamyatnin AA (1972). Protein volume in solution. In Prog Biophys Mol Biol 24, 107-123
10. Creighton TE (1984). Proteins. Structures and Molecular Properties, (New York: WH Freeman & Co.)
11. Wolfenden RV, Cullis PM and Southgate CCF (1979). Water, protein folding, and the genetic code. Science 206, 575-577
12. Statistical Sciences, Inc. (1992). S.PlusProgrammer Manual, Version 3.0, (Seattle: Statistical Sciences, Inc)
13. Sayle R (1995). RASMOL: A programme for the visualisation of proteins, nucleic acids and small molecules. In Preparation
14. Jones TA (1985). Interactive computer graphics-Frodo. Methods in Enz 115, 157-171
15. Kunkel TA (1985). Rapid and efficient site specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82, 488-492
16. McClary JA, Witney F and Geisselsoder J (1989). Efficient site-directed in vitro mutagenesis using phagemid vectors. Biotechniques 7, 282-289
17. Sanger F, Nicklen S and Coulson AR, (1977). DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74, 5463-5467
18. Rosenberg A, Lade BN, Chui D-S, Lin S-W, Dunn JJ and Studier FW (1987). Vectors for selective expression of cloned DNAs by T7 RNA polymerase. Gene 56, 5463-5467
19. Sambrook J, Fritsch EF and Maniatis T (1989). Molecular Cloning, A Laboratory Manual. 2nd Edition, pp 37-41 (New York: Cold Spring Harbor Laboratory Press)
20. Hayat MA (1986). Basic techniques For Transmission Electron Microscopy. (Orlando, Florida: Academic Press, Inc)
21. Klunk WE, Pettergrew JW and Abraham DJ (1989). Two simple methods for quantifying low-affinity-dye substrate binding. J Histochem & Cytochem 37, 1293-1297
22. Klunk WE, Pettergrew JW and Abraham DJ (1989). Quantitative evaluation of Congo red binding to amyloid-like proteins with a beta-pleated sheet conformation. J Histochem & Cytochem 37, 1273-1281
23. LeVine H (1993). Thioflavine T interaction with synthetic alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution. Protein Science 2, 404-410
24. LeVine H (1995). Thioflavine T interaction with amyloid β-sheet structures. Amyloid: Int J Exp Clin Invest 2, 1-6
25. Terry CJ, Damas AM, Oliviera P, Saraiva MJM, Alves AL, Costa PP, Matias PM, Sakaki Y and Blake CCF (1993). Structure of Met30 variant of transthyretin and its amyloidogenic implications. EMBO J 12, 735-741
26. Hamilton JA, Steinrauf LK, Leipnieks J, Benson MD, Holmgren G, Sandgren O and Steen L, (1992). Alteration in molecular structure which results in disease: The Met-30 variant of human plasma transthyretin. Biochem Biophys Acta 1139, 9-13
27. Jacobson DR, McFarlin DE, Kane I and Buxbaum JN (1992). Transthyretin Pro55, a variant associated with early onset aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 89, 353-356
28. McCutchen SL, Colon W and Kelly JW (1993). Transthyretin mutation Leu55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry 32, 12119-12127
29. Collins VP, Jacobson R, Petterson T and Carlstöm A, (1986). Monoclonal antibodies to transthyretin. Scand J Clin Lab Invest 46, 761-769
30. Blake CCF and Oatley (1977). Protein-DNA and protein hormone interaction in prealbumin. Nature 268, 115-120
31. Cornwell III GG, Sletten K, Johansson B and Westermark P (1988). Evidence that the amyloid fibrils protein in senile systemic amyloidosis is derived from normal transthyretin. Biochem Biophys Res Commun 154, 648-653
32. Felding P, Fex G, Westermark P, Olosson BO, Piykänen P and Benson L (1985). Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic poly neuropathy. Scand J Immunol 21, 133-140
33. Westermark P, Sletten K, Johansson B and Cornwell GG, (1990). Fibril in senile systemic amyloidosis is derived from normal TTR. Proc Natl Acad Sci USA 87, 2843-2845
34. Serpell LC and Blake CCF (1994). Frequency analysis and structural correlation of FAP mutations in transthyretin. In Amyloid and Amyloidosis, pp 447-450 (New York: Parthenon Publishing Group Inc.)
35. Kelly JW and Lansbury PT (1994). A chemical approach to elucidate the mechanism of transthryretin and β-protein amyloid fibril formation. Amyloid:Int J Exp Clin Invest 1, 186-205
36. Colon W and Kelly JW (1992). Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31, 8654-8660
37. Ferguson RN, Edelhoch H, Saroff HA and Robbins J (1975). Negative cooperativity in the binding of thyroxine to human serum prealbumin. Biochem 14, 282-289
38. Kraulis PJ (1991). MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures. J Appl Cryst 24, 946-950